Literature DB >> 32213297

LINC00342 regulates cell proliferation, apoptosis, migration and invasion in colon adenocarcinoma via miR-545-5p/MDM2 axis.

Zuohua Miao1, Suyun Liu2, Xuewen Xiao1, Dan Li3.   

Abstract

AIM: Colon adenocarcinoma (COAD) is the third most common cancer in the world. We aimed to explore the functional mechanism of LINC00342 in COAD.
METHODS: The LINC00342 expressions in COAD tissues were detected via qRT-PCR and in situ hybridization analysis. Statistical analysis was performed to analyze the relationship between LINC00342 expression and COAD clinical features. Small interfering LINC00342 (siLINC00342)/siCtrl were synthesized and then transfected into COAD cells. Cell apoptosis and proliferation were respectively assessed by flow cytometry and cell counting kit-8 assay. Cell migration and invasion were both measured using transwell assay. The target miRNA of LINC00342 were predicted and verified by online bioinformatics tools and luciferase reporter assay and RNA pull-down assay. Mice COAD models were constructed to explore the effects of LINC00342 on COAD in vivo.
RESULTS: LINC00342 was over-expressed in COAD tissues and LINC00342 overexpression was related to the poor prognosis of COAD patients. LINC00342 knockdown inhibited cell proliferation, migration and invasion and promoted apoptosis of COAD cells. LINC00342 targeted to miR-545-5p/murine double minute 2 (MDM2) in COAD. In COAD tissues and cell lines, LINC00342 expression was positively correlated to MDM2 expression, while it was negatively correlated to miR-545-5p expression. Both miR-545-5p-mimic and siMDM2 transfection could recover the changes of cell biological activities which were induced by LINC00342 overexpression. LINC00342 knockdown suppressed COAD tumor growth in vivo.
CONCLUSION: LINC00342 affected cell biological activities of COAD in vivo and in vitro via regulating miR-545-5p/MDM2. It might a novel target in COAD therapy.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Animal model; Colon adenocarcinoma; LIN00342; MDM2; miR-545-5p

Year:  2020        PMID: 32213297     DOI: 10.1016/j.gene.2020.144604

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  6 in total

1.  The Role of Critical N6-Methyladenosine-Related Long Non-Coding RNAs and Their Correlations with Immune Checkpoints in Renal Clear Cell Carcinoma.

Authors:  Wen Deng; Gongxian Wang; Huanhuan Deng; Yan Yan; Ke Zhu; Ru Chen; Xiaoqiang Liu; Luyao Chen; Tao Zeng; Bin Fu
Journal:  Int J Gen Med       Date:  2021-12-14

Review 2.  Long Noncoding RNAs Regulate the Radioresistance of Breast Cancer.

Authors:  Zhifeng Li; Fujin Wang; Yinxing Zhu; Ting Guo; Mei Lin
Journal:  Anal Cell Pathol (Amst)       Date:  2021-09-20       Impact factor: 2.916

3.  LncRNA LINC00342 promotes gastric cancer progression by targeting the miR-545-5p/CNPY2 axis.

Authors:  Run Liu; Xianwu Yang
Journal:  BMC Cancer       Date:  2021-10-30       Impact factor: 4.430

4.  Circular RNA UBR1 promotes the proliferation, migration, and invasion but represses apoptosis of lung cancer cells via modulating microRNA-545-5p/SSFA2 axis.

Authors:  Peng Su; Feng Mao; Jian Zhang; Hui Zhang; MingBo Wang; YanZhao Xu; ZiQiang Tian
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

5.  miR-545 promotes colorectal cancer by inhibiting transferring in the non-normal ferroptosis signaling.

Authors:  Sixin Zheng; Lingling Hu; Qingwen Song; Yuqiang Shan; Guang Yin; Hanzhang Zhu; Wencheng Kong; Chunhua Zhou
Journal:  Aging (Albany NY)       Date:  2021-12-26       Impact factor: 5.682

6.  Formononetin relieves the facilitating effect of lncRNA AFAP1-AS1-miR-195/miR-545 axis on progression and chemo-resistance of triple-negative breast cancer.

Authors:  Jingjing Wu; Wen Xu; Lina Ma; Jiayu Sheng; Meina Ye; Hao Chen; Yuzhu Zhang; Bing Wang; Mingjuan Liao; Tian Meng; Yue Zhou; Hongfeng Chen
Journal:  Aging (Albany NY)       Date:  2021-07-21       Impact factor: 5.682

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.